Amylyx Pharmaceuticals
AMLX
AMLX
178 hedge funds and large institutions have $929M invested in Amylyx Pharmaceuticals in 2023 Q4 according to their latest regulatory filings, with 37 funds opening new positions, 78 increasing their positions, 46 reducing their positions, and 28 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
178
Holders Change
+8
Holders Change %
+4.71%
% of All Funds
2.61%
Holding in Top 10
4
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-20%
% of All Funds
0.06%
New
37
Increased
78
Reduced
46
Closed
28
Calls
$50.9M
Puts
$50.4M
Net Calls
+$557K
Net Calls Change
+$7.24M
Top Buyers
| 1 |
Morgan Stanley
New York
|
$83.3M |
| 2 |
Point72 Asset Management
Stamford,
Connecticut
|
$40.5M |
| 3 |
Citadel Advisors
Miami,
Florida
|
$33M |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
$21.1M |
| 5 |
IC
Ikarian Capital
Dallas,
Texas
|
$12.9M |
